Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Bensman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 2020
Semimechanistic Modeling of Eravacycline Pharmacodynamics Using <i>In Vitro</i> Time-Kill Data with MIC Incorporated in an Adaptive Resistance FunctionKen Nguyen, Timothy J Bensman, Xiaohui Tracey Wei, et al.
Pulmonary Pharmacology & Therapeutics|July 10, 2012
Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cellsTimothy J Bensman, Albert N Nguyen, Adupa P Rao, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic FibrosisTimothy J Bensman, Joshua Wang, Jordanna Jayne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Reply to White et alEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
American Journal of Respiratory Cell and Molecular Biology|September 28, 2017
Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil RecruitmentJordanna G Jayne, Timothy J Bensman, Justin B Schaal, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Anti-Inflammatory Effects of RTD-1 in a Murine Model of Chronic <i>Pseudomonas aeruginosa</i> Lung Infection: Inhibition of NF-κB, Inflammasome Gene Expression, and Pro-IL-1β BiosynthesisMansour A Dughbaj, Jordanna G Jayne, A Young J Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe MalariaEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2015
Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosaPaul M Beringer, Timothy J Bensman, Henry Ho, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and InflammationTimothy J Bensman, Jordanna G Jayne, Meiling Sun, et al.
The Journal of Infectious Diseases|March 19, 2024
Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in AdultsHeidi L Smith, Timothy J Bensman, Shrimant Mishra, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|July 1, 2020
Semimechanistic Modeling of Eravacycline Pharmacodynamics Using <i>In Vitro</i> Time-Kill Data with MIC Incorporated in an Adaptive Resistance FunctionKen Nguyen, Timothy J Bensman, Xiaohui Tracey Wei, et al.
Pulmonary Pharmacology & Therapeutics|July 10, 2012
Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cellsTimothy J Bensman, Albert N Nguyen, Adupa P Rao, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic FibrosisTimothy J Bensman, Joshua Wang, Jordanna Jayne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Reply to White et alEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
American Journal of Respiratory Cell and Molecular Biology|September 28, 2017
Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil RecruitmentJordanna G Jayne, Timothy J Bensman, Justin B Schaal, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Anti-Inflammatory Effects of RTD-1 in a Murine Model of Chronic <i>Pseudomonas aeruginosa</i> Lung Infection: Inhibition of NF-κB, Inflammasome Gene Expression, and Pro-IL-1β BiosynthesisMansour A Dughbaj, Jordanna G Jayne, A Young J Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe MalariaEliford Kitabi, Timothy J Bensman, Justin C Earp, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2015
Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosaPaul M Beringer, Timothy J Bensman, Henry Ho, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and InflammationTimothy J Bensman, Jordanna G Jayne, Meiling Sun, et al.
The Journal of Infectious Diseases|March 19, 2024
Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in AdultsHeidi L Smith, Timothy J Bensman, Shrimant Mishra, et al.
Pageof 2